Concepedia
Statistics
Publications
48
Citations
2K
H-Index
25
Active since
1980
Affiliations
Thomas Jefferson University(Current)
XOMA (United States)
University of Oklahoma Health Sciences Center
Threshold Pharmaceuticals (United States)
Emory University
W. S. Ammons is an author at Thomas Jefferson University specializing in life sciences, neuroscience, and neurophysiology.
Publications per year
1980–2012
Potent and Highly Selective Hypoxia-Activated Achiral Phosphoramidate Mustards as Anticancer Drugs
Hailong Jiao, Jacob A. Kaizerman, Timothy F. Stanton et al. · Journal of Medicinal Chemistry · 2008 · 239 citations
Medicine, Medicinal Chemistry, Pharmacology +17
Selective Tumor Hypoxia Targeting by Hypoxia-Activated Prodrug TH-302 Inhibits Tumor Growth in Preclinical Models of Cancer
Jessica D. Sun, Qian Liu, Jingli Wang et al. · Clinical Cancer Research · 2011 · 197 citations
Pharmacy, Medicinal Chemistry, Pharmacology +16
TH-302, a hypoxia-activated prodrug with broad in vivo preclinical combination therapy efficacy: optimization of dosing regimens and schedules
Qian Liu, Jessica D. Sun, Jingli Wang et al. · Cancer Chemotherapy and Pharmacology · 2012 · 115 citations
Medicine, Medicinal Chemistry, Pharmacology +11
Vagal afferent inhibition of primate thoracic spinothalamic neurons
W. S. Ammons, Robert W. Blair, Robert D. Foreman · Journal of Neurophysiology · 1983 · 102 citations
Life Sciences, Neuroscience, Physiology +16
Vagal afferent inhibition of spinothalamic cell responses to sympathetic afferents and bradykinin in the monkey.
W. S. Ammons, Robert W. Blair, Robert D. Foreman · Circulation Research · 1983 · 87 citations
Life Sciences, Neuroscience, Physiology +15
1–5 of 48